Novel Pharmacotherapies in the Treatment of Diabetic Retinopathy

Article Figures & Data

Figures

  • Figure 1.

    Ranibizumab in Diabetic Macular Edema: DRCR Protocol I

    Reproduced from Elman M et al. Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema. Opthalmology 2010;117(6)1604–1077. With permission from Elsevier.
  • Figure 2.

    Summary of Factors Important in DME

    BM=basement membrane; EC=endothelial cell; MMP=matrix metalloproteinases; ROS=reactive oxgen species; TNF-α=tumor necrosis factor-α; VEGF=vascular endothelial growth factor.